Defense Health Agency Contracting Activity - DHACA

Description

The ARP Clinical Trial Award supports research with the potential to have a major impact on the treatment or management of ASD. Funding from this award mechanism must support a clinical trial and may not be used for preclinical research studies. The FY18 ARP Clinical Trial Award seeks applications from all areas of clinical research, and strongly encourages applications that address the critical needs of the ASD community in one or more of the following areas: • Behavioral, cognitive, and other non-pharmacological therapies • Pharmacological, genetic, and other biological treatments in ASD • Dissemination/Implementation of clinically validated interventions • Therapies to alleviate conditions co-occurring with ASD (i.e., sleep disturbances, gastrointestinal issues, inflammation, aggression, depression, anxiety, attention deficit, seizures) • Interventions promoting success in key transitions to adulthood for individuals living with ASD • Healthcare provider-focused training or tools to improve healthcare delivery for individuals with ASD across the lifespan and the continuum of care (i.e., primary care, urgent/emergent care, and disaster relief) • Improve diagnosis across the lifespan • Cultural and socioeconomic factors in treatment efficacy, delivery, and access to services

Who can apply

• Unrestricted

Contact

CDMRP Help Desk <br/>Phone: 301-682-5507 <br/>Email: help@eBRAP.org <br/>
help@eBRAP.org